Serious adverse events following treatment of visceral leishmaniasis: A systematic review and meta-analysis

BACKGROUND: Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document a...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh-Phulgenda, Sauman, Dahal, Prabin, Ngu, Roland, Maguire, Brittany J., Hawryszkiewycz, Alice, Rashan, Sumayyah, Brack, Matthew, Halleux, Christine M., Alves, Fabiana, Stepniewska, Kasia, Olliaro, Piero L, Guerin, Philippe J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031744/
https://www.ncbi.nlm.nih.gov/pubmed/33780461
http://dx.doi.org/10.1371/journal.pntd.0009302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031744/
https://www.ncbi.nlm.nih.gov/pubmed/33780461
http://dx.doi.org/10.1371/journal.pntd.0009302

Ejemplares similares